COMMISSION FOR THE PROTECTION OF COMPETITION

The Service of the Commission for the Protection of Competition on the 10th of November 2008 received on behalf of the company Ivytan AB notification of a proposed concentration according to Article 13 of the Control of Concentration between Enterprises Law (Number 22(I)/99), concerning an agreement by which Ivytan AB will proceed to a public offer in order to acquire 100% of the issued share capital of the company Q-Med AB.

” Ivytan AB” is a new enterprises whose only aim to acquire all of Q-Med AB´s share capital.

“Q-Med AB” operations concentrate in the medical sector with the development, construction and sale of implants και other goods to be used in hospitals.